Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bikram Sahoo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cancer Immunology Research|July 14, 2022
Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune ResponsesKavita Vats, Oleg Kruglov, Bikram Sahoo, et al.
Scientific Reports|February 22, 2020
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkersAngela Ogden, Shristi Bhattarai, Bikram Sahoo, et al.
International Journal of Cancer|October 11, 2018
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerPrajish Iyer, Shailesh V Shrikhande, Malika Ranjan, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cancer Immunology Research|July 14, 2022
Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune ResponsesKavita Vats, Oleg Kruglov, Bikram Sahoo, et al.
Scientific Reports|February 22, 2020
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkersAngela Ogden, Shristi Bhattarai, Bikram Sahoo, et al.
International Journal of Cancer|October 11, 2018
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerPrajish Iyer, Shailesh V Shrikhande, Malika Ranjan, et al.
Pageof 2